Form 8-K GALECTIN THERAPEUTICS For: May 11

Go back to Form 8-K GALECTIN THERAPEUTICS For: May 11

Galectin Therapeutics (GALT) Misses Q1 EPS by 2c

May 11, 2015 8:07 AM EDT

Galectin Therapeutics (NASDAQ: GALT) reported Q1 EPS of ($0.22), $0.02 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Galectin Therapeutics (GALT) click here.

... More